Company Details
Theranostics
Level 3, 62 Lygon Street, Carlton South, New South Wales, 3053, Australia
Overview
Theranostics develops methods to measure activation of signaling pathways required for molecular targeted therapies and companion diagnostics, operating in the personalized medicine space. The company is based in Philadelphia. A regulatory filing indicates Theranostics is raising $1 million in equity. On Oct. 27 the company appointed Luis T. Gutierrez as president and CEO. Gutierrez joins from a VP role at clinical research organization Aptiv Solutions. The article does not provide revenue, user metrics, or additional financial details.
- Total raised
- $1M
- Funding rounds
- 1
- Latest round
- Equity
- Latest activity
- Nov 2014
Industries
- Analytics
- Journalism
- Medical
- Publishing
Recent funding
Equity
Nov 2014
$1M
Team
No current team members are available.